Author

Fei Yi

Memorial Sloan Kettering Cancer CenterORCID 0009-0005-9031-2116Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Anthony F. DaniyaniD· 1 shared Caleb A. LareauiD· 1 shared Christopher Austin KlebanoffiD· 1 shared Christopher S. HackettiD· 1 shared Doron BeteliD· 1 shared Erica J. BrophyiD· 1 shared Friederike DündariD· 1 shared Hannah Arkin· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anthony F. DaniyanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyNature CancerPeer-reviewedJul 22, 2025

CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit

Fei Yi, Tal Cohen, Natalie Zimmerman…·Christopher Austin Klebanoff

This study identifies FASLG expression patterns and shows that FAS-L/FAS auto-regulation governs CAR-T and CAR-NK cell persistence, enhancing antitumor efficacy when FAS is inhibited.

55 citationstop 1%

humanscRNA-seq